DSS
DSS, Inc.
There isn't enough reported data to score DSS yet.
RIVN
Rivian Automotive, Inc.
RIVN lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
DSS Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Unavailable |
DSS's revenue, profitability and cash flow are currently weak. There isn't enough data to rate its balance sheet.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
DSS PE Valuation
DSS has no meaningful PE right now: it lost money over the past year.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
DSS Forward outlook
There aren't enough analyst estimates for DSS to show an outlook.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RIVN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
DSS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$5.68 | -$2.09 |
| Q2 2025 | -$6.18 | -$2.74 |
| Q1 2025 | -$6.60 | +$1.58 |
| Q4 2024 | -$6.63 | +$2.17 |
| Q3 2024 | -$3.59 | +$8.07 |
| Q2 2024 | -$3.44 | +$10.40 |
| Q1 2024 | -$8.18 | +$1.19 |
| Q4 2023 | -$8.80 | +$1.23 |
RIVN has the stronger earnings trend. Trailing diluted EPS is down 258% for DSS versus RIVN down 173%.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
DSS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3.6M | -32% |
| Q1 2026 | $4.3M | -13% |
| Q4 2025 | $4.1M | -24% |
| Q3 2025 | $6.4M | +14% |
| Q2 2025 | $5.3M | +26% |
| Q1 2025 | $5M | +28% |
| Q4 2024 | $5.4M | +101% |
| Q3 2024 | $5.6M | +34% |
DSS's revenue has slid since its 2022 peak: $4M last quarter, down 32% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -105% | -40 points |
| Q1 2026 | -127% | -52 points |
| Q4 2025 | -98% | +425 points |
| Q3 2025 | -51% | +33 points |
| Q2 2025 | -65% | +52 points |
| Q1 2025 | -75% | +46 points |
| Q4 2024 | -523% | -427 points |
| Q3 2024 | -83% | +39 points |
DSS's operating margin was −105% last quarter, down 40 points from the same quarter a year ago.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN has the edge over DSS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN has the edge over DSS on profitability, with a higher operating margin.
DSS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.9M | -195% |
| Q1 2026 | -$330K | +$1.4M |
| Q4 2025 | -$1.6M | -$1.6M |
| Q3 2025 | -$8.1M | -$4.5M |
| Q2 2025 | $2M | +$5.4M |
| Q1 2025 | -$1.7M | +$463K |
| Q4 2024 | -$5K | -100% |
| Q3 2024 | -$3.6M | -$2.2M |
DSS has burned cash in almost every quarter: −$12M over the past year, against −$3M the year before.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has the edge over DSS on cash flow, with more consistent year-over-year improvement.
DSS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.1% | +393K shares |
| 1 year | +10% | +950K shares |
| 3 years | +44% | +3.1M shares |
| 5 years | +2289% | +9.6M shares |
DSS has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
DSS Net Leverage
DSS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DSS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.6 | Neutral |
| Stochastic | 7.2 | Oversold |
DSS's weekly RSI is 42 (neutral) and its Stochastic is 7 (oversold).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
DSS PE vs Consumer Cyclical Sector
DSS has no meaningful PE right now: it lost money over the past year.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
DSS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.57 | 8.8% below |
| 20 week MA | $0.59 | 12% below |
| 50 week MA | $0.73 | 29% below |
| 100 week MA | $0.87 | 40% below |
| 200 week MA | $1.86 | 72% below |
DSS is in a downtrend: it's below all five of its weekly moving averages, and 72% below its 200-week average.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
DSS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $160.5 | $118.3 | -26% |
| 2021 | $118.3 | $14.5 | -88% |
| 2022 | $14.5 | $3.44 | -76% |
| 2023 | $3.44 | $2.40 | -30% |
| 2024 | $2.40 | $0.90 | -63% |
| 2025 | $0.90 | $0.97 | +7.8% |
| 2026 YTD | $0.97 | $0.52 | -46% |
DSS has finished lower in five of the last six years. It's down 46% so far in 2026.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has the edge over DSS on returns for 2026, with the stronger performance.